The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Karyopharm Therapeutics; Ryvu Therapeutics
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; CTI BioPharma Corp; Geron; Novartis; Ryvu Therapeutics; Sierra Oncology; Takeda; TG Therapeutics
Research Funding - ALX Oncology; Astex Pharmaceuticals; Incyte; Takeda; TG Therapeutics
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim
Risk-adjusted safety analysis of pacritinib (PAC) in patients (pts) with myelofibrosis (MF).
 
Naveen Pemmaraju
Employment - MD Anderson Cancer Center
Leadership - ASCO; ASH
Honoraria - Abbvie; Aptitude Health; Blueprint Medicines; CareDX; Celgene; DAVA Pharmaceuticals; Incyte; LFB Biotechnologies; MustangBio; NeoPharm; Novartis; Roche Molecular Diagnostics; Springer; Stemline Therapeutics
Consulting or Advisory Role - Astellas Pharma; Blueprint Medicines; Bristol Myers Squibb; Clearview Healthcare Partners; CTI BioPharma Corp; Immunogen; Pacylex; Protagonist Therapeutics; Triptych Health Partners
Research Funding - Abbvie; Affymetrix/Thermo Fisher Scientific; Cellectis; Daiichi Sankyo; MustangBio; Novartis; Plexxikon; Samus Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Abbvie; Celgene; DAVA Oncology; MustangBio; Stemline Therapeutics
(OPTIONAL) Uncompensated Relationships - Dan's House of Hope; Oncology Times
 
Bart L. Scott
Honoraria - Bristol-Myers Squibb; Incyte; Taiho Oncology
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Celgene (Inst)
 
Michael R. Savona
No Relationships to Disclose
 
Stephen T. Oh
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Disc Medicine; Geron; Incyte; PharmaEssentia
Research Funding - Actuate Therapeutics (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Sierra Oncology (Inst); Takeda (Inst)
 
Claire Harrison
Honoraria - AOP Orphan Pharmaceuticals; BMSi; Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Geron; Novartis; Roche/Genentech
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Celgene; Galectin Therapeutics; Promedior; Sierra Oncology
Speakers' Bureau - Celgene; CTI BioPharma Corp; Gilead Sciences; Incyte; Janssen Oncology; Novartis
Research Funding - Celgene (Inst); Constellation Pharmaceuticals (Inst); Novartis (Inst)
 
Alessandro M. Vannucchi
Consulting or Advisory Role - Abbvie; AOP Orphan Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; Incyte; Novartis
Speakers' Bureau - Abbvie; AOP Orphan Pharmaceuticals; Blueprint Medicines; Bristol-Myers Squibb; Incyte; Novartis
 
Francesca Palandri
Honoraria - AOP Orphan Pharmaceuticals; Celgene; CTI; Novartis; Sierra Oncology
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Celgene; CTI; Novartis; Sierra Oncology
 
Haifa Kathrin Al-Ali
Honoraria - Abbvie; BMSi; Incyte (Inst); Novartis; Pfizer; Takeda
Consulting or Advisory Role - Abbvie; BMSi; Novartis
Research Funding - BMSi (Inst); Incyte (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BMSi; Novartis; Novartis
 
Marta Sobas
Honoraria - Celgene; CTI BioPharma Corp; Novartis
Consulting or Advisory Role - Celgene; CTI BioPharma Corp; Novartis
 
Mary Frances McMullin
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Incyte; Novartis; Sierra Oncology
Speakers' Bureau - Abbvie; AOP Orphan Pharmaceuticals; Incyte; Novartis; Pfizer
 
Vikas Gupta
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; Novartis; Pfizer; Sierra Oncology
Consulting or Advisory Role - Celgene; Novartis; Roche; Sierra Oncology
Research Funding - Novartis (Inst)
 
Ruben A. Mesa
Consulting or Advisory Role - Constellation Pharmaceuticals; La Jolla Pharma; Novartis; Sierra Oncology
Research Funding - Abbvie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Genentech (Inst); Incyte (Inst); Mays Cancer Center (Inst); NCI (Inst); Promedior (Inst); Samus (Inst)
 
Sarah Buckley
Employment - CTI BioPharma Corp
Stock and Other Ownership Interests - CTI BioPharma Corp
Travel, Accommodations, Expenses - CTI BioPharma Corp
 
Karisse Roman-Torres
Employment - Providence Health and Services
Stock and Other Ownership Interests - CTI BioPharma Corp
Consulting or Advisory Role - CTI BioPharma Corp
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Sierra Oncology
Research Funding - AbbVie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Galecto (Inst); Geron (Inst); Incyte (Inst); Kartos Therapeutics (Inst); PharmaEssentia (Inst); Protagonist Therapeutics (Inst); Sierra Oncology (Inst); Telios (Inst)
 
Abdulraheem Yacoub
Consulting or Advisory Role - Acceleron Pharma; Agios; CTI BioPharma Corp; Novartis
Speakers' Bureau - Incyte